Antibody to Epstein-Barr Nuclear Antigen A (IgG) - Serum
This test measures your immune response to the Epstein-Barr virus (EBV), a common virus that can cause infections like mononucleosis. It helps determine if you’ve been exposed to EBV and whether your immune system has developed antibodies against it.
["Assessing past or current EBV exposure through antibody detection."]
Key facts at a glance
- LOINC
- 26023-2
- Short code
- ENA Ab Ser
- Synonyms
- ENA Ab Ser
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
This test measures IgG antibodies that your immune system makes against Epstein-Barr virus nuclear antigen, known as EBNA. A positive result shows that your body has encountered the Epstein-Barr virus in the past, which helps your doctor tell the difference between an older, resolved infection and one that started recently.
The test detects IgG antibodies specific to Epstein-Barr Nuclear Antigen A (EBNA A), a protein produced by the Epstein-Barr virus. These antibodies appear in your blood after your immune system has encountered the virus. The presence of these antibodies indicates a past or ongoing infection, though IgG alone doesn’t distinguish between acute or chronic infection.
Doctors order this test when patients have symptoms such as lasting tiredness, fever, sore throat, or swollen lymph nodes, or when earlier Epstein-Barr virus results need to be clarified. It helps confirm a past infection and rule out other conditions that can cause similar complaints.
Healthcare providers may order this test to diagnose or monitor Epstein-Barr virus infections, such as infectious mononucleosis, or to evaluate conditions like chronic fatigue syndrome, lymphoproliferative disorders, or in certain autoimmune diseases where EBV is suspected. It can also be used in research or for screening in high-risk populations.
The sample is a small amount of blood drawn from a vein in your arm, usually at a laboratory or clinic. Little or no preparation is needed, and you may normally eat, drink, and take your regular medicines. Let the person drawing your blood know if you bruise easily or take blood thinners.
A blood sample is drawn from a vein in your arm. The blood is processed to separate serum (the liquid part without clotting factors) for testing. This serum is then analyzed to detect the presence of EBNA IgG antibodies using an immunoassay method.
Before the test, a healthcare professional will explain the procedure and answer your questions. An elastic band is placed around your upper arm so the vein is easier to see, and the blood draw itself takes only a few minutes. Most people can return to their normal activities right away.
There are no special preparations needed for this test. You may have some mild discomfort or bruising at the injection site, but this usually resolves quickly. If you’re on blood-thinning medication or have a history of bleeding disorders, let your provider know before the test.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance
Short name
EBNA IgG Antibody (Serum)
Frequently asked questions
A positive result for EBNA IgG antibodies suggests past exposure to EBV, as these antibodies persist long-term in the blood. While they don’t indicate the current state of your infection, they can help confirm a diagnosis of EBV-related conditions. However, they do not differentiate between active infection and latent (inactive) virus presence. High antibody levels may also be seen in individuals with certain autoimmune diseases or after organ transplantation.
A positive result means your immune system has likely encountered the Epstein-Barr virus at some point, producing antibodies against EBNA A. This does not necessarily mean you currently have an active infection, but it confirms past exposure. Further testing may be needed to assess current viral activity or related health conditions.
Yes, antibody levels can fluctuate, but IgG antibodies to EBNA A are generally stable over months to years. They do not typically rise or fall significantly unless there is an active EBV infection or another immune response affecting the virus.
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy